•1 min read•from Science News
The COVID-19 vaccine may offer brain cancer patients a surprise benefit
A recent shot of the COVID-19 vaccine doubled survival time in glioblastoma patients who had undergone tumor biopsy or surgery.
Want to read more?
Check out the full article on the original site
Tagged with
#COVID-19 vaccine
#glioblastoma
#brain cancer
#survival time
#tumor biopsy
#surgery
#immunotherapy
#oncology
#cancer treatment
#patient outcomes
#clinical trial
#mRNA vaccine
#neurology
#tumor microenvironment
#immune response
#biopsy
#immunological effects
#therapeutic benefit
#prognosis
#cancer research